1-3 of 3
Christophe Piguet, MD
Close
Sort by
Journal Articles

Pediatric-Onset Evans Syndrome Is Associated with Broad Immunopathological Manifestations, High Treatment Burden and Mortality in Long-Term Follow-up

Thomas Pincez, MD, Helder Fernandes, PhD, Thierry Leblanc, MD, Gérard Michel, MD, Vincent Barlogis, MD, PhD, Yves Bertrand, MD, Bénédicte Neven, MD, PhD, Wadih Abou Chahla, MD, Marlène Pasquet, MD, PhD, Corinne Guitton, MD, M.Sc., Aude Marie-Cardine, MD, Isabelle Pellier, MD, PhD, Corinne Armari-Alla, MD, Joy Benadiba, MD, Pascale Blouin, MD, Eric Jeziorski, MD, Frederic Millot, MD, Catherine Paillard, MD PhD, Caroline Thomas, MD, Nathalie Cheikh, MD, Sophie Bayard, MD, Fanny Fouyssac, MD, Christophe Piguet, MD, Mariana Deparis, MD, Claire Briandet, MD, Eric Doré, MD, Judith Landman-Parker, MD, PhD, Guy Leverger, MD, Nathalie Aladjidi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–22.
https://doi.org/10.1182/blood-2020-133778
Published: 2020
Journal Articles

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Andre Baruchel, PhD, MD, Arnaud Petit, Thierry Leblanc, Gérard Michel, Yves Perel, MD, PhD, Francoise Mechinaud, MD, Virginie Gandemer, Claudine Schmitt, MD, Pascale Schneider, Benoit Brethon, MD, Anne Auvrignon, Caroline Thomas, M.D., Geneviève Margueritte, Christiane Vermylen, MD, PhD, Odile Lejars, MD, Isabelle Pellier, Claire Berger, MD, Gérard Couillault, Catherine Paillard, Christian Berthou, MD, Christophe Piguet, MD, Brigitte Pautard, MD, Jean Soulier, MD, PhD, Nathalie Grardel, Kheira Beldjord, Marie-Francoise Auclerc, Elizabeth Macintyre, MD, PhD, Jean-Michel Cayuela, PhD, Sylvie Chevret, Guy Leverger, MD
Journal: Blood
Blood (2012) 120 (21): 135.
https://doi.org/10.1182/blood.V120.21.135.135
Published: 2012
Journal Articles

Two Decades of Progresses in Adolescents with Acute Lymphoblastic Leukemia (ALL) Treated in the FRALLE Protocols: Adolescence Is No More a Bad Prognostic Feature If an Intensive Chemotherapy Is Applied.

Andre Baruchel, MD, Marie-Françoise Auclerc, MD, Yves Perel, MD, Françoise Mechinaud, MD, Anne Auvrignon, MD, Claudine Schmitt, MD, Christophe Piguet, MD, Odile Lejars, MD, Christian Berthou, MD, François Demeocq, MD, Pascale Schneider, MD, Virginie Gandemer, MD, Gérard Michel, MD, Jean-Michel Cayuela, Pharm D, Thierry Leblanc, MD, Guy Leverger, MD, the FRALLE Group
Journal: Blood
Blood (2006) 108 (11): 1852.
https://doi.org/10.1182/blood.V108.11.1852.1852
Published: 2006